Viewing Study NCT01004159


Ignite Creation Date: 2025-12-24 @ 2:28 PM
Ignite Modification Date: 2025-12-26 @ 1:04 PM
Study NCT ID: NCT01004159
Status: TERMINATED
Last Update Posted: 2015-10-19
First Post: 2009-10-28
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Cetuximab Plus Irinotecan in Colorectal Cancer Patients Who Progressed After Failure With Cetuximab Plus Irinotecan
Sponsor: Roswell Park Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Colorectal cancer View
None KRAS wild type tumors View